Evaluation of Serologic Responses to Fluzone in Infants at least 6 Months of Age Who Did or Did Not Receive Fluzone Vaccine at 2 Months of Age

Trial Profile

Evaluation of Serologic Responses to Fluzone in Infants at least 6 Months of Age Who Did or Did Not Receive Fluzone Vaccine at 2 Months of Age

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Apr 2014

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 22 Apr 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top